Latest articles and price-sensitive announcements with AI sentiment classification.
Starpharma posted a sharp rise in FY26 revenue and narrowed its loss, with new funds extending its cash runway into FY28. The post Starpharma: FY26 earnings reveal strong revenue growth and improved loss appeared first on The Motley Fool Australia.
Highlights Starpharma Holdings is drawing attention after strong insider accumulation alongside robust earnings and revenue expectations. Several Australian growth companies with notable insider ownership continue to stand out despite broader market volatility. Healthcare, aged care and mining businesses remain in focus as market conditions shift. Australia's share market continues to navigate a cautious environment as global developments, including stronger oil prices and geopolitical u...
director_dealing announcement
director_dealing announcement
director_dealing announcement
director_dealing announcement
director_dealing announcement
capital_raise announcement
Starpharma Holdings (ASX:SPL): The Pharmaceutical Innovator Behind One of the ASX's Strongest Healthcare Returns Kalkine
Can Starpharma (ASX:SPLR) Build on Its Recent Momentum as Oncology Programs Advance? Kalkine
Starpharma (ASX:SPL) Records a Mild Decline While Holding Favourable Annual Gains Kalkine
UBS Group AG along with its associated corporate entities officially ceased to be a substantial shareholder in StarPharma Holdings Limited (ASX: SPL) on 17 July 2026, as disclosed in a Form 605 notice submitted to the company. Between 22 and 24 June 2026, UBS executed a series of buy and sell transactions involving ordinary shares of the Australian biopharmaceutical firm, resulting in its relevant interest falling below the substantial holding threshold. This marks a notable shift in the shareho...
Starpharma Holdings (ASX:SPLR) Shares Slide 15.39%: What Pressured the Biotechnology Stock? Kalkine
capital_raise announcement
Starpharma Holdings (ASX:SPL) Unlocks New Milestone in Radiopharmaceutical Partnership Kalkine
Starpharma Holdings (ASX:SPL) Shares Climb as Radiopharmaceutical Program Gains Momentum Kalkine
other announcement
other announcement
Why Starpharma Holdings (ASX:SPL) Shares Decline 6% on Friday? Kalkine
other announcement
other announcement
other announcement
director_dealing announcement
other announcement
other announcement
other announcement
other announcement
director_dealing announcement
other announcement
director_dealing announcement
Motley Fool
ASX
Kalkine
Google News